These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18362965)

  • 1. A peptide hydroxamate library for enrichment of metalloproteinases: towards an affinity-based metalloproteinase profiling protocol.
    Geurink P; Klein T; Leeuwenburgh M; van der Marel G; Kauffman H; Bischoff R; Overkleeft H
    Org Biomol Chem; 2008 Apr; 6(7):1244-50. PubMed ID: 18362965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M; Tordai H; Trexler M; Bányai L; Patthy L
    Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase synthesis of succinylhydroxamate peptides: functionalized matrix metalloproteinase inhibitors.
    Leeuwenburgh MA; Geurink PP; Klein T; Kauffman HF; van der Marel GA; Bischoff R; Overkleeft HS
    Org Lett; 2006 Apr; 8(8):1705-8. PubMed ID: 16597146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.
    Sylte I; Dawadi R; Malla N; von Hofsten S; Nguyen TM; Solli AI; Berg E; Adekoya OA; Svineng G; Winberg JO
    PLoS One; 2018; 13(8):e0200237. PubMed ID: 30075004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides.
    Tuccinardi T; Martinelli A; Nuti E; Carelli P; Balzano F; Uccello-Barretta G; Murphy G; Rossello A
    Bioorg Med Chem; 2006 Jun; 14(12):4260-76. PubMed ID: 16483784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel series of highly selective inhibitors of MMP-3.
    Whitlock GA; Dack KN; Dickinson RP; Lewis ML
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6750-3. PubMed ID: 18029177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.
    Kolodziej SA; Hockerman SL; DeCrescenzo GA; McDonald JJ; Mischke DA; Munie GE; Fletcher TR; Stehle N; Swearingen C; Becker DP
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3561-4. PubMed ID: 20529685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid assembly of matrix metalloprotease inhibitors using click chemistry.
    Wang J; Uttamchandani M; Li J; Hu M; Yao SQ
    Org Lett; 2006 Aug; 8(17):3821-4. PubMed ID: 16898826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2).
    Rossello A; Nuti E; Orlandini E; Carelli P; Rapposelli S; Macchia M; Minutolo F; Carbonaro L; Albini A; Benelli R; Cercignani G; Murphy G; Balsamo A
    Bioorg Med Chem; 2004 May; 12(9):2441-50. PubMed ID: 15080939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.
    Santos MA; Enyedy EA; Nuti E; Rossello A; Krupenko NI; Krupenko SA
    Bioorg Med Chem; 2007 Feb; 15(3):1266-74. PubMed ID: 17127067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK; Green BG; Kozarich JW
    Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of potent MMP inhibitors into selective TACE inhibitors.
    Cherney RJ; King BW; Gilmore JL; Liu RQ; Covington MB; Duan JJ; Decicco CP
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1028-31. PubMed ID: 16289878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases.
    Skarja GA; Brown AL; Ho RK; May MH; Sefton MV
    Biomaterials; 2009 Apr; 30(10):1890-7. PubMed ID: 19147221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors.
    Santos MA; Marques SM; Tuccinardi T; Carelli P; Panelli L; Rossello A
    Bioorg Med Chem; 2006 Nov; 14(22):7539-50. PubMed ID: 16875829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.
    Noe MC; Snow SL; Wolf-Gouveia LA; Mitchell PG; Lopresti-Morrow L; Reeves LM; Yocum SA; Liras JL; Vaughn M
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4727-30. PubMed ID: 15324896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.
    Noe MC; Natarajan V; Snow SL; Mitchell PG; Lopresti-Morrow L; Reeves LM; Yocum SA; Carty TJ; Barberia JA; Sweeney FJ; Liras JL; Vaughn M; Hardink JR; Hawkins JM; Tokar C
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2808-11. PubMed ID: 15911259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of matrix metalloproteinase active forms in complex proteomes: evaluation of affinity versus photoaffinity capture.
    Bregant S; Huillet C; Devel L; Dabert-Gay AS; Beau F; Thai R; Czarny B; Yiotakis A; Dive V
    J Proteome Res; 2009 May; 8(5):2484-94. PubMed ID: 19271733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-based matrix metallo-protease enrichment using automated, inhibitor affinity extractions.
    Freije JR; Klein T; Ooms JA; Franke JP; Bischoff R
    J Proteome Res; 2006 May; 5(5):1186-94. PubMed ID: 16674108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.
    Yang SM; Scannevin RH; Wang B; Burke SL; Wilson LJ; Karnachi P; Rhodes KJ; Lagu B; Murray WV
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1135-9. PubMed ID: 18086526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.
    Sjøli S; Nuti E; Camodeca C; Bilto I; Rossello A; Winberg JO; Sylte I; Adekoya OA
    Eur J Med Chem; 2016 Jan; 108():141-153. PubMed ID: 26638045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.